Alpha DNA Investment Management’s KLA KLAC Stock Holding History

Alpha DNA Investment Management’s Portfolio KLAC Stock Details KLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,950	Closed	-$1.19M	–	94
2024 Q4	$1.19M	Sell	18,950 -3,420	-15%	-$231K	0.45%	40
2024 Q3	$1.73M	Buy	22,370 +14,300	+177%	+$1.12M	0.65%	34
2024 Q2	$665K	Sell	8,070 -2,750	-25%	-$203K	0.26%	82
2024 Q1	$756K	Sell	10,820 -13,280	-55%	-$853K	0.28%	83
2023 Q4	$1.4M	Buy	+24,100	New	+$1.25M	0.55%	36
2022 Q4	–	Sell	-23,380	Closed	-$707K	–	176
2022 Q3	$707K	Buy	+23,380	New	+$810K	0.59%	59
2021 Q2	–	Sell	-1,700	Closed	-$56K	–	374
2021 Q1	$56K	Sell	1,700 -710	-29%	-$21.4K	0.06%	158
2020 Q4	$62K	Buy	+2,410	New	+$56.2K	0.07%	155

Other funds holding KLAC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alpha DNA Investment Management's KLAC Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of KLA (KLAC) in Q1 2025, closing a stake of 18,950 shares — an estimated $1.19M sold.

Alpha DNA Investment Management first reported a position in KLAC in Q4 2020 and held it in 8 quarters. The position peaked at $1.73M in Q3 2024. 1,562 funds tracked by Wall St. Rank hold KLAC as of Q1 2025.

Alpha DNA Investment Management reported no remaining KLA position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 18,950 KLA shares in Q1 2025, an estimated $1.19M.
Alpha DNA Investment Management first reported a position in KLA in Q4 2020 and held it in 8 quarters.
Alpha DNA Investment Management's KLA position peaked at $1.73M in Q3 2024.
1,562 funds tracked by Wall St. Rank held KLA as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.